Dr. Marijn Visschedijk Maag-Darm-Lever arts

Wetenschappelijke publicaties

• Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
• Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease
• Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
• Vaginal delivery in women with perianal Crohn's disease: why not?
• Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review
• Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
• Exposure toThioguanine During 117 Pregnancies inWomen With Inflammatory Bowel Disease
• Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion
• The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients
• Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification
• Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease
• Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures
• Mindfulness-Based Cognitive Therapy for Fatigue in Patients with Inflammatory Bowel Disease: Results of a Randomized Controlled Trial
• Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
• Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases
• Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
• Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry
• A Rare Case of Protein-Losing Enteropathy, Alopecia, Hyperpigmentation and Dystrophy of the Nails: A Case Report
• Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
• Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
• The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease: A Systematic Literature Review
• Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
• Use of Tumor Necrosis Factor-α Antagonists is Associated with Attenuated IgG Antibody Response against SARS-CoV-2 in Vaccinated Patients with Inflammatory Bowel Disease
• Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients with Crohn’s Disease
• Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study
• Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease
• In-depth characterisation of the serum antibody epitope repertoire in Inflammatory Bowel Disease by high-throughput phage-displayed immunoprecipitation sequencing
• Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease
• Proteomic analyses do not reveal subclinical inflammation in fatigued patients with quiescent Inflammatory Bowel Disease
• Mucosal microbiota modulate host intestinal immune signatures in Inflammatory Bowel Disease
• Use of TNF-α-antagonists and systemic steroids is associated with attenuated imunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease
• Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn's disease
• Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn's disease
• Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
• A Combined mRNA- and miRNA-Sequencing Approach Reveals miRNAs as Potential Regulators of the Small Intestinal Transcriptome in Celiac Disease
• Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
• The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
• Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8+T cells and an infiltration pattern that resembles ulcerative colitis
• Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn's disease
• Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with Ulcerative Colitis
• The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease
• Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease
• Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn's disease undergoing infliximab induction therapy
• CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
• Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
• CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
• Isotype specific antibody responses to Mycobacterium Avium subspecies Paratuberculosis antigens are associated with the use of biological therapy in Inflammatory Bowel Disease
• Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis
• Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients
• Cigarette smoke increases risk for colorectal neoplasia in inflammatory bowel disease